Editas Medicine, Inc

Orbital Therapeutics, based in Cambridge, MA, is dedicated to advancing RNA medicines aimed at expanding access to innovative therapies for patients with various diseases. Their cutting-edge platform integrates RNA discovery and design, focusing on immune reprogramming to help restore health by delivering precise molecular instructions directly to immune cells. The company emphasizes a culture of collaboration and has assembled a team experienced in transitioning medicines from concept to clinical application. Through their comprehensive RNA platform, Orbital Therapeutics seeks to engineer durable therapies with the flexibility needed to effectively modulate disease outcomes. Generated from the website

In operation since 1981, Genzyme Corporation is one of the leading biotechnology companies in the world. The company employs a staff of more than 12,000 people and manages over 85 locations in nearly 40 countries. It focuses on the areas of hematologic oncology, biosurgery, transplant, genetic diseases, and cardiometabolic and renal. Genzyme Corporation offers Fabrazyme, which is a solution for intravenous infusion. The company also provides Fabrazyme, Renagel, Renvela and Hectorol. It offers solutions for the medical and patient communities. In addition, Genzyme Corporation offers Synvisc, which is a viscosupplementation treatment for relieving knee pain associated with osteoarthritis. The company provides Sepra, which is a line of hyaluronic acid-based products.

OncoPep, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative cancer immunotherapies. With a strong focus on scientific research and clinical trials, OncoPep aims to revolutionize cancer treatment by harnessing the power of the immune system to target and eliminate cancer cells. Through their cutting-edge pipeline and dedication to advancing cancer therapeutics, OncoPep is committed to making a significant impact in the fight against cancer, offering hope to patients worldwide. With a global presence, including a branch in Seoul, Republic of Korea, OncoPep is at the forefront of the biotech industry, striving to improve patient outcomes and transform the future of cancer care.Generated from the website